Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Diazoxide, minoxidil sulphate, and cromakalim relax rat blood vessels by opening K+ channels, with some differences in their actions.

Venusia CeraPlus cream and lotion effectively reduce eczema severity and improve skin moisture.

A heterozygous mutation in HTRA1 can cause severe CARASIL symptoms.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Cryptotanshinone may help treat postmenopausal osteoporosis and protect kidneys.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Diuretics help the body get rid of excess salt and water by acting on the kidneys in different ways.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Nanocrystals improve alopecia areata treatment by better targeting hair follicles.

CaM7 and CNGC14 interaction controls root hair growth in Arabidopsis.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

KATP channel openers may cause peripheral edema by reducing lymphatic contractions and flow.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

A new pomegranate extract lowers blood pressure and has health benefits.